Maajo 8, 2022, Epiprobe waxa ay ku dhawaaqday in ay si madaxbanaan u samaysay saddex xidhmo ogaanshaha hiddasidaha kansarka: TAGMe DNA Methylation Kits (qPCR) ee Kansarka Makaanka afkiisa, TAGMe DNA Methylation Kits (qPCR) ee Kansarka Endometrial ) Kansarka kaadi mareenka, waxay heleen shahaadada CE ee EU waxaana lagu iibin karaa wadamada EU iyo wadamada CE la aqoonsan yahay.
Muuqaallada codsiga ee dhammaystiran ee saddexda xirmooyinka ogaanshaha methylation DNA
Saddexda qalab ee kor ku xusan waxay si fiican ugu habboon yihiin mashiinnada qPCR ee suuqa.Uma baahna daaweynta bisulfit, waxay ka dhigaysaa habka ogaanshaha mid fudud oo habboon.Halbeegga methylation-ka ee lagu dabaqi karo dhammaan noocyada kansarka caadiga ah.
Xaaladaha codsiga ee TAGMe DNA Methylation Kits (qPCR) ee Kansarka Makaanka afkiisa oo ay ku jiraan:
● Baaritaanka kansarka ilmo-galeenka ee haweenka ka weyn 30 sano
● Qiimaynta khatarta ah ee haweenka qaba HPV
● Baadhista caawimada ee kansarka ilmagaleenka squamous cell carcinoma iyo adenocarcinoma
La socodka soo noqoshada qalliinka ka dib ee kansarka ilmo galeenka
Xaaladaha codsiga ee TAGMe DNA Methylation Kits (qPCR) ee Kansarka Endometrial oo ay ku jiraan:
● Baaritaanka kansarka endometrial ee dadka khatarta sare leh
● Buuxinta farqiga u dhexeeya ogaanshaha molecular ee kansarka endometrial
La socodka soo noqoshada qalliinka ka dib ee kansarka endometrial
Xaaladaha codsiga ee TAGMe DNA Methylation Kits (qPCR) ee Kansarka kaadi mareenka oo ay ku jiraan:
● Baaritaanka kansarka kaadi mareenka ee dadka khatarta sare leh
● Baaritaanka hore ee cystoscopy-ga bukaan-socodka
● Qiimaynta natiijooyinka daaweynta qaliinka ee bukaanada qaba kansarka kaadiheysta
● Qiimaynta kiimoterabiga ee bukaanka qaba kansarka kaadiheysta
La socoshada soo noqoshada qalliinka ka dib ee kansarka kaadi mareenka
Habka Epiprobe'globalization si dhakhso leh ayuu u socdaa, alaabtuna waxay ka gudubtay shahaadada CE ee Midowga Yurub.
Waqtigan xaadirka ah, Epiprobe waxay aasaastay koox diiwaangelin xirfadeed.
Dhanka kale, marka lagu daro baahida hal-abuurka leh ee sahaminta calaamadaha kansarka pan-kansarka iyo ogaanshaha saaxiibka, Epiprobe waxay sii waday horumarinta balaadhinta qaybta badeecada iyo hal-abuurka R&D.Tan iyo markii saddexda xirmooyinka ogaanshaha hiddasidaha methylation kansarka ay heleen shahaadada EU CE, taasoo muujineysa in alaabadani ay waafaqsan yihiin tilmaamaha aaladda caafimaadka ee EU in vitro diagnostic reagent qalabyada la xiriira, waxaana lagu iibin karaa wadamada xubnaha ka ah EU iyo wadamada aqoonsan shahaadada EU CE.Tani waxay sii kobcin doontaa khadka wax soo saarka ee shirkadda, waxay kor u qaadi doontaa guud ahaan tartanka, waxayna dhammaystiri doontaa qaabkeeda ganacsi ee caalamiga ah.
Ms. Hua Lin, oo ah madaxa shirkadda Epiprobe ayaa tiri:
Dadaalka wadajirka ah ee diiwaangelinta shirkadda, R&D, maaraynta tayada, suuqgeynta iyo waaxyo kale, Epiprobe waxay heshay shahaadada EU CE ee alaabada lagu ogaado kansarka ilmo-galeenka, kansarka endometrial, iyo kansarka kaadi mareenka.Waad ku mahadsan tahay dadaalkaas, aagga iibinta Epiprobe waxaa lagu ballaariyay Midowga Yurub iyo gobollada la xidhiidha, taas oo qaadaysa tallaabo adag oo loo qaadayo xaqiijinta qaabka iibka caalamiga ah ee alaabta shirkadda."Epiprobe waxay si qoto dheer u kobcin doontaa suuqa caalamiga ah ee baaritaanka kansarka hore, waxayna horumarin doontaa suuqyada caalamiga ah iyo kanaalada, waxay ku tiirsan tahay maaraynta tayada iyo nidaamka diiwaangelinta, hababka maaraynta shaybaadhka adduunka ugu horreeya iyo tignoolajiyada ogaanshaha methylation, iyadoo la adeegsanayo tignoolajiyada iyo alaabooyinka ugu horumarsan si loo caawiyo dadka caalamka , waxay faa'iido u leedahay caafimaadka caalamka.
Ku saabsan CE
Calaamadaynta CE waxaa loola jeedaa calaamad midaysan oo qasab ah oo badeecada ah oo loogu talagalay wadamada EU.Calaamadeynta CE waxay muujineysaa in alaabadu ay waafaqsan yihiin shuruudaha aasaasiga ah ee ay dejiyeen shuruucda Yurub ee ku habboon caafimaadka, badbaadada, ilaalinta deegaanka iyo ilaalinta macaamiisha, alaabooyinkan waxaa si sharci ah loogu geli karaa laguna faafin karaa suuqa kaliya ee EU.
Ku saabsan Epiprobe
Waxaa la aasaasay 2018, Epiprobe, oo ah taageere iyo hormoodka hore ee baaritaanka kansarka pan-cancer, waa shirkad tignoolajiyadeed sare leh oo diiradda saareysa ogaanshaha unugyada kansarka iyo warshadaha dawooyinka saxda ah.Iyada oo lagu dhisayo kooxda ugu sareysa ee khabiirada epigenetics iyo ururinta tacliinta qoto dheer, Epiprobe waxay sahamisaa goobta ogaanshaha kansarka, waxay ilaalisaa aragtida "ka ilaalinta qof walba kansarka," oo ay ka go'an tahay ogaanshaha hore, ogaanshaha hore iyo daaweynta hore ee kansarka, taas oo hagaajin doonta heerka badbaadada bukaanka kansarka iyo kor u qaadida caafimaadka dadka oo dhan.
Waqtiga boostada: Meey-08-2022